On November 7, 2019 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") reported that it will attend the 25th Annual BIO-Europe International Partnering Conference being held November 11 – 13, 2019 at the Hamburg Messe in Hamburg, Germany (Press release, Actinium Pharmaceuticals, NOV 7, 2019, View Source [SID1234550619]). Actinium will participate in the 1-on-1 partnering meetings and will make a company presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of Actinium’s presentation are as follows:

Date: Tuesday, November 12, 2019
Time: 3:30 PM CEST
Venue: Level 0, Hall B1, Room 4

Members of Actinium’s Executive team will be available for one-on-one meetings with conference attendees. Those interested in scheduling a meeting with Actinium may do so by contacting David Gould, MD, Senior Vice President, Corporate Development and Affairs via email at [email protected].

About the BIO-Europe International Partnering Conference

BIO-Europe is the preeminent partnering conference of the European life science industry, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities and private one-to-one meetings. The BIO-Europe 2019 partnering event is expected to draw over 4,300 industry attendees for three days of high-level networking, representing upwards of 2,300 companies from over 60 countries. To learn more about the conference, please visit the BIO-Europe 2019 webpage.